The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Association of increased interferon‐inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus
Abstract
Objective: To study 5 type I interferon (IFN)–inducible genes (LY6E, OAS1, OASL, MX1, and ISG15) in patients with systemic lupus erythematosus (SLE) and to correlate expression levels with disease activity and/or clinical manifestations. Methods: Peripheral blood cells were obtained from 48 SLE patients, 48 normal controls, and 22 rheumatic disease controls, and total RNA was extracted and reverse transcribed into complementary DNA. Gene expression levels were measured by real‐time polymerase chain reaction, standardized to a housekeeping gene, and summed to an IFN score. Disease activity was determined by the Safety of Estrogens in Lupus Erythematosus: National Assessment–Systemic Lupus Erythematosus Disease Activity Index (SELENA‐SLEDAI) composite. Results: Each gene was highly expressed in SLE patients compared with normal controls (P ≤ 0.0003) or disease controls (P ≤ 0.0008 except for MX1). IFN scores were positively associated with the SELENA‐SLEDAI instrument score (P = 0.001), the SELENA‐SLEDAI flare score (P = 0.03), and the physician's global assessment score (P = 0.005). Compared with patients without nephritis, lupus nephritis patients had higher IFN scores (overall P < 0.0001), especially during active renal disease. IFN scores were weakly associated with neurologic manifestations. Elevated IFN scores were positively associated with the current presence of anti–double‐stranded DNA (anti‐dsDNA) antibodies (P = 0.007) or hypocomplementemia (P = 0.007). LY6E expression levels distinguished active from inactive lupus nephritis (P = 0.02) and were positively associated with proteinuria (P = 0.009). Conclusion: The 5 IFN‐inducible genes were highly expressed in SLE patients, and increased levels were correlated with disease activity defined by several methods. IFN scores, or LY6E levels, were elevated in lupus nephritis patients, especially during active renal disease, and in patients with anti‐dsDNA antibody positivity and hypocomplementemia. IFN scores, or LY6E levels, may be useful as a biomarker for lupus nephritis therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
The Scree Test For The Number Of Factors
Cattell, R. B. (1966) · Multivariate Behavioral Research · doi:10.1207/s15327906mbr0102_10 · Cited by 13,554
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Prevoo, M. L. L., Van'T Hof, M. A., Kuper, H. H., Van Leeuwen, M. A., Van De Putte, L. B. A., & Van Riel, P. L. C. M. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380107 · Cited by 6,243
Derivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,240
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,958
Leavitt, R. Y., Fauci, A. S., Bloch, D. A., Michel, B. A., Hunder, G. G., Arend, W. P., Calabrese, L. H., Fries, J. F., Lie, J. T., Lightfoot, R. W., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330807 · Cited by 1,947
Computer-Aided Multivariate Analysis
Afifi, A. A., & Clark, V. (1996) · Springer eBooks · doi:10.1007/978-1-4899-3342-3 · Cited by 1,358
Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus
Blanco, P., Palucka, A. K., Gill, M., Pascual, V., & Banchereau, J. (2001) · Science · doi:10.1126/science.1064890 · Cited by 1,266
Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus
Petri, M., Kim, M. Y., Kalunian, K. C., Grossman, J., Hahn, B. H., Sammaritano, L. R., Lockshin, M., Merrill, J. T., Belmont, H. M., Askanase, A. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051135 · Cited by 1,166
Self-citationBarrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., Chang, B., Duramad, O., & Coffman, R. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050914 · Cited by 928
Farkas, L., Beiske, K., Lund-Johansen, F., Brandtzaeg, P., & Jahnsen, F. L. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61689-6 · Cited by 730
Kirou, K. A., Lee, C., George, S., Louca, K., Peterson, M. G. E., & Crow, M. K. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21031 · Cited by 701
Buyon, J. P., Petri, M. A., Kim, M. Y., Kalunian, K. C., Grossman, J., Hahn, B. H., Merrill, J. T., Sammaritano, L., Lockshin, M., Alarcón, G. S., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_1-200506210-00004 · Cited by 661
Self-citationDiscovering statistically significant pathways in expression profiling studies
Tian, L., Greenberg, S. A., Kong, S. W., Altschuler, J., Kohane, I. S., & Park, P. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506577102 · Cited by 648
Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice
Santiago-Raber, M.-L., Baccala, R., Haraldsson, K. M., Choubey, D., Stewart, T. A., Kono, D. H., & Theofilopoulos, A. N. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021996 · Cited by 509
Bengtsson, A. A., Sturfelt, G., Truedsson, L., Blomberg, J., Alm, G., Vallin, H., & Rönnblom, L. (2000) · Lupus · doi:10.1191/096120300674499064 · Cited by 464
Identification of XAF1 as an antagonist of XIAP anti-Caspase activity
Liston, P., Fong, W. G., Kelly, N. L., Toji, S., Miyazaki, T., Conte, D., Tamai, K., Craig, C. G., McBurney, M. W., & Korneluk, R. G. (2001) · Nature Cell Biology · doi:10.1038/35055027 · Cited by 441
Coordinate overexpression of interferon‐α–induced genes in systemic lupus erythematosus
Kirou, K. A., Lee, C., George, S., Louca, K., Papagiannis, I. G., Peterson, M. G. E., Ly, N., Woodward, R. N., Fry, K. E., Lau, A. Y., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20798 · Cited by 418
Båve, U., Nordmark, G., Lövgren, T., Rönnelid, J., Cajander, S., Eloranta, M., Alm, G. V., & Rönnblom, L. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20998 · Cited by 390
Vitali, C., Bencivelli, W., Isenberg, D. A., Smolen, J. S., Snaith, M. L., Sciuto, M. E., Neri, R., & Bombardieri, S. (1992) · PubMed · Cited by 317
Classification and definition of major flares in SLE clinical trials
Petri, M., Buyon, J., & Kim, M. (1999) · Lupus · doi:10.1191/096120399680411281 · Cited by 282
Self-citationMathian, A., Weinberg, A., Gallegos, M., Banchereau, J., & Koutouzov, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2499 · Cited by 270
Han, G.-M., Chen, S.-L., Shen, N., Ye, S., Bao, C.-D., & Gu, Y.-Y. (2003) · Genes & Immunity · doi:10.1038/sj.gene.6363966 · Cited by 264
(1988) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068256 · Cited by 218
Microarray analysis of gene expression in lupus.
Crow, M. K., & Wohlgemuth, J. G. (2003) · Arthritis Research · doi:10.1186/ar1015 · Cited by 184
Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice
Braun, D. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(02)00109-9 · Cited by 182
Niewold, T. B., & Swedler, W. I. (2005) · Clinical Rheumatology · doi:10.1007/s10067-004-1024-2 · Cited by 179
Computer-aided Multivariate Analysis
Ziegel, E. R. (2004) · Technometrics · doi:10.1198/tech.2004.s241 · Cited by 165
Tissue expression, structure and function of the murine Ly‐6 family of molecules
GUMLEY, T. P., MCKENZIE, I. F., & SANDRIN, M. S. (1995) · Immunology & Cell Biology · doi:10.1038/icb.1995.45 · Cited by 159
(2004) · Arthritis & Rheumatism · doi:10.1002/art.20628 · Cited by 138
Role of Natural Interferon-α Producing Cells (Plasmacytoid Dendritic Cells) in Autoimmunity
Rönnblom, L., Eloranta, M., & Alm, G. V. (2003) · Autoimmunity · doi:10.1080/08916930310001602128 · Cited by 137
Bae, S.-C., Koh, H.-K., Chang, D.-K., Kim, M.-H., Park, J. K., & Kim, S. Y. (2001) · Lupus · doi:10.1191/096120301678646146 · Cited by 121
Self-citationHartmann, R. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.18.4121 · Cited by 116
Meraro, D., Gleit-Kielmanowicz, M., Hauser, H., & Levi, B.-Z. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6224 · Cited by 105
Kälkner, K. M. (1998) · QJM · doi:10.1093/qjmed/91.6.393 · Cited by 104
Combined Oral Contraceptives in Women With Systemic Lupus Erythematosus
Petri, M., Kim, M., KALUNIAN, K. C., Grossman, J., Hahn, B. H., Sammaritano, L. R., Lockshin, M. D., Merrill, J. T., Belmont, M. H., Askanase, A., et al. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000206335.34330.35 · Cited by 94
Self-citationAutoimmune Phenomena in Patients with Malignant Carcinoid Tumors During Interferon-α Treatment
Rönnblom, L., Alm, G. V., & Öberg, K. (1991) · Acta Oncologica · doi:10.3109/02841869109092414 · Cited by 90
Yu, M., Tong, J., Mao, M., Kan, L., Liu, M.-M., Sun, Y., Fu, G., Jing, Y., Yu, L., Paslier, D. L., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7406 · Cited by 78
Kitamura, A., Takahashi, K., Okajima, A., & Kitamura, N. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00877.x · Cited by 69
Andes virus stimulates interferon‐inducible MxA protein expression in endothelial cells
Khaiboullina, S. F., Rizvanov, A. A., Deyde, V., & Jeor, S. C. S. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20266 · Cited by 60
Pflugh, D. L., Maher, S. E., & Bothwell, A. L. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5130 · Cited by 50
Kametaka, S., Shibata, M., Moroe, K., Kanamori, S., Ohsawa, Y., Waguri, S., Sims, P. J., Emoto, K., Umeda, M., & Uchiyama, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208611200 · Cited by 47
Schiffenbauer, J., Hahn, B., Weisman, M. H., & Simon, L. S. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20353 · Cited by 36
Self-citationChen, H., Frissora, F. W., Durbin, J. E., & Muthusamy, N. (2003) · Cellular Immunology · doi:10.1016/j.cellimm.2003.09.006 · Cited by 21
Ly-6A/E induction by interleukin-6 and interleukin-9 in T cells.
Demoulin, J., Maisin, D., & Renauld, J. (1999) · PubMed · Cited by 18
Kumar, K. R., Zhu, J., Bhaskarabhatla, M., Yan, M., & Mohan, C. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.09.015 · Cited by 12
Cited by
Tsokos, G. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1100359 · Cited by 2,736
Vitamin D and the immune system
Aranow, C. (2011) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31821b8755 · Cited by 1,436
Structure and Degradation of Circular RNAs Regulate PKR Activation in Innate Immunity
Liu, C.-X., Li, X., Nan, F., Jiang, S., Gao, X., Guo, S.-K., Xue, W., Cui, Y., Dong, K., Ding, H., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.046 · Cited by 807
Tang, Y., Luo, X., Cui, H., Ni, X., Yuan, M., Guo, Y., Huang, X., Zhou, H., de Vries, N., Tak, P. P., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24436 · Cited by 735
Type I Interferon in the Pathogenesis of Lupus
Crow, M. K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1002795 · Cited by 561
Metadata
- Authors
- Feng, X., Wu, H., Grossman, J. M., Hanvivadhanakul, P., FitzGerald, J. D., Park, G. S., Dong, X., Chen, W., Kim, M. H., Weng, H. H., Furst, D. E., Gorn, A., McMahon, M., Taylor, M., Brahn, E., Hahn, B. H., & Tsao, B. P.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2006-08-31
- Volume
- 54
- Issue
- 9
- Pages
- 2951-2962
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2039378822
- Cited by
- 487
- References
- 53
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.